ConductScience.org, home

Paper1369413

Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.

Clynes M and 3 others. Cytotechnology, 1992. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A. Papers, record 1369413. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1369413

Download JSON
Cell line
DLKP-A2 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.
PubMed
Journal
Cytotechnology
PubMed
Year
1992
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.87
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clynes MM
2Redmond AA
3Moran EE
4Gilvarry UU

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
DoxorubicinMajor topic
Drug ResistanceMajor topic
Lung NeoplasmsMajor topic
Base Sequence
Blotting, Western
Chromosome Banding
Culture Techniques
Fluorescent Antibody Technique
Genetic Variation
Glycoproteins
Humans
Male
Metaphase
Middle Aged
Molecular Sequence Data
Oligonucleotides, Antisense
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11968221Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.Mol Pharmacol1990https://conductscience.org/library/papers/1968221PubMed
25432063Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature1970https://conductscience.org/library/papers/5432063PubMed
31706611
Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule.
Ann Oncol1990https://conductscience.org/library/papers/1706611PubMed
41967222Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.Cancer Res1990https://conductscience.org/library/papers/1967222PubMed
56819318Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy.J Immunol Methods1982https://conductscience.org/library/papers/6819318PubMed
63843705Measurement of protein using bicinchoninic acid.Anal Biochem1985https://conductscience.org/library/papers/3843705PubMed
71309222Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.Cancer Res1992https://conductscience.org/library/papers/1309222PubMed
81717144Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.Cancer Res1991https://conductscience.org/library/papers/1717144PubMed
92746668MDR1 gene expression in lung cancer.J Natl Cancer Inst1989https://conductscience.org/library/papers/2746668PubMed
101371598Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein.Nature1992https://conductscience.org/library/papers/1371598PubMed
111310250Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill.Br J Cancer1992https://conductscience.org/library/papers/1310250PubMed
121374941Is the multidrug transporter a flippase?Trends Biochem Sci1992https://conductscience.org/library/papers/1374941PubMed
131581877Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines.Cancer Genet Cytogenet1992https://conductscience.org/library/papers/1581877PubMed
141672252Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.Br J Cancer1991https://conductscience.org/library/papers/1672252PubMed
152553990Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.J Natl Cancer Inst1989https://conductscience.org/library/papers/2553990PubMed
162466554Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.Cancer Res1989https://conductscience.org/library/papers/2466554PubMed
172899442Mechanism of multidrug resistance.Biochim Biophys Acta1988https://conductscience.org/library/papers/2899442PubMed
182033016Acid phosphatase: endpoint for in vitro toxicity tests.In Vitro Cell Dev Biol1991https://conductscience.org/library/papers/2033016PubMed
192217530Pharmacology of drugs that alter multidrug resistance in cancer.Pharmacol Rev1990https://conductscience.org/library/papers/2217530PubMed
201688652Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/1688652PubMed

See all 30 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
38226983Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.Cancer Chemother Pharmacol2024https://conductscience.org/library/papers/38226983PubMed
36291610Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells.Biomolecules2022https://conductscience.org/library/papers/36291610PubMed
33076245Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression.Int J Mol Sci2020https://conductscience.org/library/papers/33076245PubMed
28881357A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.Br J Cancer2017https://conductscience.org/library/papers/28881357PubMed
27270313
The impact of intermittent versus continuous exposure to EGFR tyrosine kinase inhibitor on selection of EGFR T790M-mutant drug-resistant clones in a lung cancer cell line carrying activating EGFR mutation.
Oncotarget2016https://conductscience.org/library/papers/27270313PubMed
24639951In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies.Front Oncol2014https://conductscience.org/library/papers/24639951PubMed
24052043The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance.Br J Cancer2013https://conductscience.org/library/papers/24052043PubMed
23589314The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias.Cancer Chemother Pharmacol2013https://conductscience.org/library/papers/23589314PubMed
20607587Modulation of P-gp expression by lapatinib.Invest New Drugs2011https://conductscience.org/library/papers/20607587PubMed
19499189Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines.Invest New Drugs2010https://conductscience.org/library/papers/19499189PubMed
19002787Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.Cytotechnology1998https://conductscience.org/library/papers/19002787PubMed
9378810A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.J Clin Pathol1997https://conductscience.org/library/papers/9378810PubMed
8862012Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines.Cytotechnology1996https://conductscience.org/library/papers/8862012PubMed
8862007mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.Cytotechnology1996https://conductscience.org/library/papers/8862007PubMed
8096505Cellular models for multiple drug resistance in cancer.In Vitro Cell Dev Biol1993https://conductscience.org/library/papers/8096505PubMed
7765329Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.Cytotechnology1993https://conductscience.org/library/papers/7765329PubMed
7765327Human cell lines as models for multidrug resistance in solid tumours.Cytotechnology1993https://conductscience.org/library/papers/7765327PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1369413

GET https://conductscience.org/api/papers/v1/1369413/references?page=2